Phase 3 CoMpass trial fully enrolled with 108 patients, exceeding enrollment target; on track for topline data in 2H 2027Strategic operating plan ...

Phase 3 CoMpass trial fully enrolled with 108 patients, exceeding enrollment target; on track for topline data in 2H 2027 Strategic operating plan refined to focus on development of bel-sar in ocular ...

In its "most significant regulatory milestone", Oncosil can sell its rare bile duct cancer treatment in the US in a ... Read ...

Good day, and thank you for standing by. Welcome to the Bicara Therapeutics Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...

Good afternoon, and welcome to the Spero Therapeutics Second Quarter 2026 Earnings Conference Call. Please be advised that this call is being recorded, and a replay will be available. You can find the ...

Spread the loveEli Lilly is on the verge of a monumental moment, one that could redefine the landscape of obesity treatment and, frankly, the company’s financial future for decades. We’re talking ...

At this time, I would like to welcome you to the Kymera Therapeutics Second Quarter 2026 Results Call. [Operator Instructions ...

Operator: My name is Julianne, and I will be your conference facilitator today for the Amgen Q2 Earnings Conference Call. I ...

Scientists are searching some of Earth’s oldest rocks for tiny fossils that could reveal how simple microbial life made the ...

Every day, billions of cells in our body die and are removed as part of normal tissue maintenance. This continuous cleanup process is essential for keeping the immune system in balance and preventing ...